arupsan 200 mg tabletter
accord healthcare b.v. - eslicarbazepinacetat - tabletter - 200 mg
arupsan 800 mg tabletter
accord healthcare b.v. - eslicarbazepinacetat - tabletter - 800 mg
phenergan 1 mg/ml oral opløsning
opella healthcare france sas - promethazinhydrochlorid - oral opløsning - 1 mg/ml
upstaza
ptc therapeutics international limited - eladocagene exuparvovec - aminosyre-metabolisme, infødte fejl - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.
sastravi 100+25+200 mg filmovertrukne tabletter
actavis group ptc ehf. - carbidopamonohydrat, entacapon, levodopa - filmovertrukne tabletter - 100+25+200 mg
sastravi 150+37,5+200 mg filmovertrukne tabletter
actavis group ptc ehf. - carbidopamonohydrat, entacapon, levodopa - filmovertrukne tabletter - 150+37,5+200 mg
sastravi 50+12,5+200 mg filmovertrukne tabletter
actavis group ptc ehf. - carbidopamonohydrat, entacapon, levodopa - filmovertrukne tabletter - 50+12,5+200 mg
sastravi 75+18,75+200 mg filmovertrukne tabletter
actavis group ptc ehf. - carbidopamonohydrat, entacapon, levodopa - filmovertrukne tabletter - 75+18,75+200 mg
shingrix
glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - vacciner - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. brug af shingrix bør være i overensstemmelse med de officielle anbefalinger.
sastravi 125+31,25+200 mg filmovertrukne tabletter
actavis group ptc ehf. - carbidopamonohydrat, entacapon, levodopa - filmovertrukne tabletter - 125+31,25+200 mg